A Multicenter, Randomized, Open Label, Parallel Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf in Stable Liver Transplantation Patients and a Pharmacokinetics Study.
Phase of Trial: Phase III
Latest Information Update: 26 Feb 2016
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 11 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Mar 2009 Actual patient number (172) added as reported by ClinicalTrials.gov.
- 10 Mar 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.